Literature DB >> 22674696

Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.

Fnu Rafiullah1, Sunil Kanwal, Usman M Majeed, Mark A Korsten, Faisal H Cheema, Munish Luthra, Muhammad Rizwan Sohail.   

Abstract

A 78-year-old, retired Caucasian male presented in emergency room with 3 days history of progressive watery diarrhoea. Two weeks earlier, he received intravenous levofloxacin for community acquired pneumonia. The patient was diagnosed as severe Clostridium difficile infection based on clinical presentation, labs and imaging studies. The patient was initially treated with intravenous metronidazole and oral vancomycin. While awaiting subacute rehabilitation placement, the patient relapsed twice. After first recurrence the patient was treated with 2 weeks of oral nitazoxanide. After second recurrence, the patient was treated 2 weeks of nitazoxanide followed by tapering dose of vancomycin. The patient was followed and no relapse was reported at 1 year follow-up visit.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22674696      PMCID: PMC3229312          DOI: 10.1136/bcr.04.2011.4123

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

Review 1.  Recurrent clostridium difficile.

Authors:  Seema Maroo; J Thomas Lamont
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

2.  Nitazoxanide for the treatment of Clostridium difficile colitis.

Authors:  Daniel M Musher; Nancy Logan; Richard J Hamill; Herbert L Dupont; Arnold Lentnek; Arvind Gupta; Jean-Francois Rossignol
Journal:  Clin Infect Dis       Date:  2006-07-11       Impact factor: 9.079

Review 3.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

4.  Recurrence of symptoms in Clostridium difficile infection--relapse or reinfection?

Authors:  M H Wilcox; W N Fawley; C D Settle; A Davidson
Journal:  J Hosp Infect       Date:  1998-02       Impact factor: 3.926

5.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Authors:  Fred A Zar; Srinivasa R Bakkanagari; K M L S T Moorthi; Melinda B Davis
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

Review 6.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

Review 7.  Clinical recognition and diagnosis of Clostridium difficile infection.

Authors:  John G Bartlett; Dale N Gerding
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

Review 8.  Treatment of Clostridium difficile infection.

Authors:  Dale N Gerding; Carlene A Muto; Robert C Owens
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

9.  Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

Authors:  Rocco Ricciardi; David A Rothenberger; Robert D Madoff; Nancy N Baxter
Journal:  Arch Surg       Date:  2007-07

10.  Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.

Authors:  Marya D Zilberberg; Andrew F Shorr; Marin H Kollef
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more
  4 in total

Review 1.  The potential for emerging therapeutic options for Clostridium difficile infection.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Gut Microbes       Date:  2014

Review 2.  Management of adult Clostridium difficile digestive contaminations: a literature review.

Authors:  Fanny Mathias; Christophe Curti; Marc Montana; Charléric Bornet; Patrice Vanelle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-29       Impact factor: 3.267

Review 3.  Novel Antimicrobials for the Treatment of Clostridium difficile Infection.

Authors:  Nicola Petrosillo; Guido Granata; Maria Adriana Cataldo
Journal:  Front Med (Lausanne)       Date:  2018-04-16

4.  Frontiers in antibiotic alternatives for Clostridioides difficile infection.

Authors:  Matthew Phanchana; Phurt Harnvoravongchai; Supapit Wongkuna; Tanaporn Phetruen; Wichuda Phothichaisri; Supakan Panturat; Methinee Pipatthana; Sitthivut Charoensutthivarakul; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  World J Gastroenterol       Date:  2021-11-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.